Fennec Pharmaceuticals (FENC) Free Cash Flow Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 4.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.30% |
| Sep 30, 2025 | 31.96% |
| Jun 30, 2025 | -2.83% |
| Mar 31, 2025 | -14.77% |
| Dec 31, 2024 | 23.13% |
| Sep 30, 2024 | 9.31% |
| Jun 30, 2024 | -23.75% |
| Mar 31, 2024 | 131.35% |
| Dec 31, 2023 | -13.96% |
| Sep 30, 2023 | 20.27% |
| Jun 30, 2023 | -8.19% |
| Mar 31, 2023 | -14.16% |
| Dec 31, 2022 | -62.34% |
| Sep 30, 2022 | -30.87% |
| Jun 30, 2022 | -7.15% |
| Mar 31, 2022 | -4.83% |
| Dec 31, 2021 | -3.46% |
| Sep 30, 2021 | -22.76% |
| Jun 30, 2021 | -41.27% |
| Mar 31, 2021 | -27.66% |
| Dec 31, 2020 | -35.50% |
| Sep 30, 2020 | -78.47% |
| Jun 30, 2020 | -65.45% |
| Mar 31, 2020 | -77.09% |
| Dec 31, 2019 | -37.55% |
| Sep 30, 2019 | -60.16% |
| Jun 30, 2019 | -80.33% |
| Mar 31, 2019 | -70.63% |
| Dec 31, 2018 | -90.47% |
| Sep 30, 2018 | -46.46% |
| Jun 30, 2018 | -45.38% |
| Mar 31, 2018 | -60.46% |
| Dec 31, 2017 | -41.29% |
| Sep 30, 2017 | -29.32% |
| Jun 30, 2017 | -18.83% |
| Mar 31, 2017 | -21.32% |
| Dec 31, 2016 | -11.15% |
| Sep 30, 2016 | -5.07% |
| Jun 30, 2016 | 19.14% |
| Mar 31, 2016 | -7.03% |
| Dec 31, 2015 | 8.69% |
| Sep 30, 2015 | 11.16% |
| Jun 30, 2015 | 23.31% |
| Mar 31, 2015 | 10.24% |
| Dec 31, 2014 | 15.18% |
| Sep 30, 2014 | 11.36% |
| Jun 30, 2014 | -30.67% |
| Mar 31, 2014 | 28.82% |
| Dec 31, 2013 | 12.09% |
| Sep 30, 2013 | 5.17% |
| Jun 30, 2013 | -32.06% |